491 BASECAMP-1: an observational study to identify relapsed solid tumor patients with human leukocyte antigen (HLA) loss of heterozygosity (LOH) and leukapheresis for future CAR T-cell therapy

• Yi Lin,
• Diane Simeone,
• Armen Mardiros,
• Scott Kopetz,
• David Maloney,
• Sandip Patel,
• Julian Molina,
• William Go,
• Kirstin Liechty,
• Michelle Fan-Port,
• Jason Perera,
• Karl Beutner,
• Ariane Lozac’hmeur,
• Eric Ng,
• J Randolph Hecht

Affiliations

Yi Lin

Public Health Sciences Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, USA

Diane Simeone

20 New York University Medical Center, New York City, New York, USA

Armen Mardiros

Aff1 grid.410425.60000000404218357Hematology & Hematopoietic Cell TransplantationBeckman Research Institute and City of Hope National Medical Center Duarte CA USA

Scott Kopetz

GI Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, Texas, USA

David Maloney

Critical Care Medicine, Children`s Hospital of Pittsburgh of University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania, USA

Sandip Patel

3University of California at San Diego, La Jolla, California, USA

Julian Molina

1Mayo Clinic, Rochestser, MN, USA

William Go

2A2 Biotherapeutics, Inc., Agoura Hills, CA, USA

Kirstin Liechty

2A2 Biotherapeutics, Inc., Agoura Hills, CA, USA

Michelle Fan-Port

2A2 Biotherapeutics, Inc., Agoura Hills, CA, USA

Jason Perera

6former Tempus, Chicago, IL, USA

Karl Beutner

7Tempus, Chicago, IL, USA

Ariane Lozac’hmeur

7Tempus, Chicago, IL, USA

Eric Ng

2A2 Biotherapeutics, Inc., Agoura Hills, CA, USA

J Randolph Hecht

9David Geffen School of Medicine at UCLA, Los Angeles, USA